Ovarian cancer in infertile women during or after ovulation-induction therapy: Expression of LH/hCG receptors and sex steroid receptors

International Journal of Gynecological Cancer

Volumn 7, Issue 6, 1997, Pages 451-457

  Kuroda, H ^a   Konishi, I ^a   Mandai, M ^a   Nanbu, K ^a   Rao, Ch V ^b   Mori, T ^a  

^a KYOTO UNIVERSITY   (Japan)

^b University of Louisville School of Medicine   (United States)

Author keywords

Infertility; LH hCG receptor; Ovarian cancer; Ovulation induction; Sex steroid receptor

Indexed keywords

CHORIONIC GONADOTROPIN RECEPTOR; ESTROGEN RECEPTOR; LUTEINIZING HORMONE RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; ARTICLE; CANCER RISK; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FEMALE INFERTILITY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; OVARY CANCER; OVULATION INDUCTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RISK ASSESSMENT;

EID: 0031449178     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1438.1997.09753.x     Document Type: Article

References (49)

1. Bristow RE, Karlan BY. The risk of ovarian cancer after treatment for infertility. Curr Opinion Obstet Gynecol 1996; 8: 32-37.
2. Fathalla DM. Incessant ovulation - A factor in ovarian neoplasia? Lancet 1971; ii: 163.
3. Whittemore AS, Harris R, Itnyre J, Halpern J. The COCG. Characteristics relating to ovarian cancer risk: Collaborative analysis of 12 US case-control studies. Am J Epidemiol 1992; 136: 1175-1220.
4. Cohen J, Forman R, Harlap S, et al. IFFS expert group report on the Whittemore study related to the risk of ovarian cancer associated with the use of infertility agents. Hum Reprod 1993; 8: 996-999.
5. Shoham Z. Epidemiology, etiology, and fertility drugs in ovarian epithelial carcinoma: Where are we today? Fertil Steril 1994; 62: 433-448.
6. Helzlsouer KJ, Alberg AJ, Gordon GB, et al. Serum gonadotropins and steroid hormones and the development of ovarian cancer. JAMA 1995; 27: 1926-1930.
7. Tarlatzis BC, Grimbizis G, Bontis J, Mantalenakis S. Ovarian stimulation and ovarian tumours: A critical reappraisal. Hum Reprod Update 1995; 1: 284-301.
8. Longo DL, Young RC. The natural history and treatment of ovarian cancer. Ann Rev Med 1981; 32: 475-490.
9. Mandai M, Konishi I, Kuroda H, et al. Messenger ribonucleic acid expression of LH/hCG receptor gene in human ovarian carcinomas. Eur J Cancer 1997; 33: 1501-1507.
10. Lei ZM, Toth P, Rao CV, Pridham D. Novel coexpression of human chorionic gonadotropin (hCG)/human luteinizing hormone receptors and their ligand hCG in human fallopian tubes. J Clin Endocrinol Metab 1993; 77: 863-872.
11. Lin J, Lei ZM, Lojun S, et al. Increased expression of luteinizing hormone/human chorionic gonadotropin receptor gene in human endometrial carcinomas. J Clin Endocrinol Metab 1994; 79: 1483-1491.
12. Komatsu T, Konishi I, Mandai M, et al. Peritoneal papillary serous carcinoma arising in an infertile woman during ovulation-induction therapy: Immunohistochemical expression of LH/hCG receptors. Gynecol Oncol 1995; 56: 470-447.
13. Kobayashi F, Monma C, Nanbu K, et al. Rapid growth of an ovarian clear cell carcinoma expressing LH/hCG receptor arising from endometriosis during early pregnancy. Gynecol Oncol 1996; 62: 309-313.
14. Koshiyama M, Konishi I, Mandai M, et al. Immunohistochemical analysis of p53 protein and 72 kDa heat shock protein (HSP72) in ovarian carcinomas: correlation with clinicopathology and sex steroid receptor status. Virchows Archiv 1995; 425: 603-609.
15. Bamford PN, Steele SJ. Uterine and ovarian carcinoma in a patient receiving gonadotropin therapy. Case report. Br J Obstet Gynaecol 1982; 89: 962-964.
16. Atlas M, Menczer J. Massive hyperstimulation and borderline carcinoma of the ovary. A possible association. Acta Obstet Gynecol Scand 1982; 61: 261-263.
17. Ben-Hur H, Dagni R, Lancet M, et al. Ovarian carcinoma masquerading as ovarian hyperstimulation syndrome. Acta Obstet Gynecol Scand 1986; 65: 813-814.
18. Carter ME, Joyce DN. Ovarian carcinoma in a patient hyperstimulated by gonadotropin therapy for in vitro fertilization. A case report. J in Vitro Fertil Embryo Trans 1987; 4: 126-128.
19. Kulkarni R, McGarry JM. Follicular stimulation and ovarian cancer. Br Med J 1989; 299: 740.
20. Dietl J. Ovulation and ovarian cancer. Lancet 1991; 338: 445.
21. Goldberg GL, Runowicz CD. Ovarian carcinoma of low malignant potential, infertility, and induction of ovulation - Is there a link? Am J Obstet Gynecol 1992; 166: 853-854.
22. Nijman HW, Burger CW, Baak JPA, et al. Borderline malignancy of the ovary and controlled hyperstimulation. A report of 2 cases. Eur J Cancer 1992; 28A: 1971-1973.
23. Lopes P, Julou V, Mensier A, et al. Cancer de l'ovaire et procreation medicalement assistee. Contracept Fertil Sexual 1992; 20: 797-798.
24. Balasch J, Barri PN. Follicular stimulation and ovarian cancer? Hum Reprod 1993; 8: 990-996.
25. Lopes P, Mensier A. Ovarian cancer and assisted reproductive technology. Eur J Obstet Gynecol Reprod Biol 1993; 51: 171-173.
26. Karlan BY, Marrs R, Lagasse LD. Advanced stage ovarian carcinoma presenting during infertility evaluation. Am J Obstet Gynecol 1994; 171: 1377-1378.
27. Grimbizis G, Tarlatzis BC, Bontis J, et al. Two cases of ovarian tumours in women who had undergone multiple ovarian stimulation attempts. Hum Reprod 1995; 10: 520-523.
28. Nanbu Y, Tatsumi S, Kashu I. Ovarian cancer arising in women with a child-bearing desire. Report of two cases. Adv Obstet Gynecol 1995; 47: 379-387.
29. Hull ME, Kriner M, Schneider E, Maiman M. Ovarian cancer after successful ovulation induction. A case report. J Reprod Med 1996; 41: 52-54.
30. Bristow RE, Karlan BY. Stage IV ovarian carcinoma following ovulation induction: A report of three cases. Int J Gynecol Cancer 1997; 7: 112-6.
31. Rajaniemi H, Kaupilla A, Rönnberg L, et al. LH (hCG) receptor in benign and malignant tumors of human ovary. Acta Obstet Gynecol Scand (Suppl.) 1981; 101: 83-86.
32. Kammerman S, Demopoulos RI, Raphael C, Ross J. Gonadotropic hormone binding to human ovarian tumors. Hum Pathol 1981; 12: 886-90.
33. Stouffer RL, Grodin MS, Davis JR, Surwit EA. Investigation of binding sites for follicle-stimulating hormone and chorionic gonadotropin in human ovarian cancers. J Clin Endocrinol Metab 1984; 59: 441-446.
34. Nakano R, Kitayama R, Yamoto M, et al. Localization of gonadotropin binding sites in human ovarian neoplasms. Am J Obstet Gynecol 1989; 161: 905-910.
35. Simon WE, Albrecht M, Hänsel M, et al. Cell lines derived from human ovarian carcinomas: Growth stimulation by gonadotropic and steroid hormones. J Natl Cancer Inst 1983; 70: 839-844.
36. Wimalasena J, Dostal R, Meehan D. Gonadotropins, estradiol, and growth factors regulate epithelial ovarian cancer cell growth. Gynecol Oncol 1992; 46: 345-350.
37. Ohtani K, Sakamoto H, Sato K. Stimulatory effects of follicular stimulating hormone on the proliferation of ovarian cancer cell line in vitro and in vivo. Acta Obst Gynaec Jpn 1992; 44: 717-724.
38. Kataoka A, Nishida T, Motomura S, et al. The effects of sex steroid hormones, gonadotropins, and gonadotropin releasing hormone agonist on the proliferation of ovarian cancer cell line (KOC-2S). Acta Obst Gynaec Jpn 1994; 46: 1033-1040.
39. Kuroda H, Konishi I, Mandai M, et al. Expression of LH/hCG receptors in ovarian cancer cells and the effect of hCG on the tumor cell apoptosis (Abstract): In: Proceedings of 55th Annual Meeting of The Japanese Cancer Association. Jpn J Cancer Res (Suppl.) 1996; 303.
40. Rose PG, Peale FR, Longcope C, Hunter RE. Prognostic significance of estrogen and progesterone receptors in epithelial ovarian cancer. Obstet Gynecol 1990; 76: 258-263.
41. Harding M, Cowan S, Hole D, et al. Estrogen and progesterone receptors in ovarian cancer. Cancer 1990; 65: 486-491.
42. Kommos F, Pfisterer J, Thome M, Schäfer W, Sauerbrei W, Pfleiderer A. Steroid receptors in ovarian carcinoma: Immunohistochemical determination may lead to new aspects. Gynecol Oncol 1992; 47: 317-322.
43. Konishi I, Koshiyama M, Mandai M, et al. Sex steroid receptors, LH/hCG receptor, and oncogene expression in endometrial carcinomas. In: Genazzani AR, Petraglia F, D'Ambrogio G, Genazzani AD, Artini PG, eds. Recent Developments in Gynecology and Obstetrics. Carnforth: Parthenon Publishing, 1996; 715-719.
44. Konishi I, Koshiyama M, Mandai M, et al. Increased expression of LH/hCG receptors in endometrial hyperplasia and carcinoma in anovulatory women. Gynecol Oncol 1997; 65: 273-280.
45. Rossing MA, Daling JR, Weiss NS, Moore DE, Self SG. Ovarian tumors in a cohort of infertile women. New Engl J Med 1994; 331: 771-776.
46. Shushan A, Elchalal U, Paltiel O, Peretz T, Iscovich J, Schenker JG. Human menopausal gonadotropin and risk of epithelial ovarian cancer. Fertil Steril 1996; 65: 13-18.
47. Franceschi S, Vecchia CL, Negri E, et al. Fertility drugs and risk of ovarian cancer in Italy. Hum Reprod 1994; 9: 1673-1675.
48. Venn A, Watson L, Lumley J, Giles G, King C, Healy D. Breast and ovarian cancer incidence after infertility and in vitro fertilisation. Lancet 1995; 346: 995-1000.
49. Komatsu T, Konishi I, Mandai M, et al. Adnexal masses. Transvaginal US and gadolinium-enhanced MR imaging assessment of intratumoral structure. Radiology 1996; 198: 109-115.